Histogenics’ NeoCart Phase I/Phase II Clinical Trial Data
Results from Phase I and Phase II study indicate that Histogenics’ NeoCart® tissue-engineered implant is a safe, effective treatment for articular...
Results from Phase I and Phase II study indicate that Histogenics’ NeoCart® tissue-engineered implant is a safe, effective treatment for articular...
OssDsign entered into new commercial partnerships covering distribution of its products for cranial repair and facial bone reconstruction in Italy,...
Six new patents were granted to Spinal Simplicity in 2016, bringing its portfolio to 52 globally. A new Notice of...
Medovex entered into an international distribution agreement with AlfaMed for distribution of its DenerveXâ„¢ System throughout Italy....
Strategic orthopaedic-related 510(k)s issued in December 2016 include: Envision 3D Image Guidance System (7D Surgical); Sphynx Anterolateral Plate (Eden Spine);...
Cartiva secured US $8.5MM in a Series E financing. Proceeds will support commercialization of the Synthetic Cartilage Implant for treatment of great...
Orthofix announced U.S. FDA premarket and European CE Mark approval for next-gen CervicalStim™ and SpinalStim™ bone growth stimulators....
Medicrea filed its FDA 510(k) submission for 3D-printed titanium interbody devices with compatible UNiD™ Lab surgical planning and analytical services. ...
CartiHeal announced initial cases in Europe with the next-gen version of the Agili-C™ unicondylar implant, designed to treat large cartilage lesions....
Johnson & Johnson Medical Devices, parent company to DePuy Synthes, announced CareAdvantage and Orthopaedic Episode of Care Approach services for healthcare...
Login
Register for a free account
As a guest member you get access to more articles and videos every month.